Behavioral/Psychosocial Interventions

  • The ASAM Fundamentals of Addiction Medicine 40-Hour CME Program (Online)

    Contains 65 Product(s)

    ​The ASAM Fundamentals of Addiction Medicine 40-Hour Program is an innovative educational program empowering primary care and other providers to identify, treat, and/or refer patients at risk for or with addiction. The curriculum is designed for healthcare professionals who received little addiction education during their medical training.​

  • The ASAM Review Course in Addiction Medicine 2019 (20.5 CME)

    Contains 24 Product(s)

    Earn up to 20.5 CME while preparing for the ABPM Addiction Medicine Exam using this on-demand package of courses, containing the conference recordings, resources, practice questions, and slides from The ASAM Review Course in Addiction Medicine, 2019. The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

  • ASAM 50th Annual Conference - Innovations in Addiction Medicine and Science - 2019 (85 CME)

    Contains 63 Product(s)

    Earn a maximum of 85 AMA PRA Category 1™ credits while learning about the latest innovations in Addiction Medicine and Science from these on-demand conference recordings from the nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine.

  • Annual Review of Addiction Medicine: Highest Impact Publications for 2018-2019 (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the most important research and scholarly developments in the addiction field from The ASAM 50th Annual Conference (2019).

  • The ASAM Pain & Addiction: Common Threads XX 2019 (8 CME)

    Contains 11 Product(s)

    Participants will learn clinical best practices and new research developments for treating patients with pain and addiction and how to begin to integrate these techniques into their own practices.

  • The ASAM Treatment of Opioid Use Disorder Course 8-Hour Online

    Contains 6 Component(s), Includes Credits

    This course covers all approved medications to treat opioid use disorder and provides the 8 hours of education needed to receive a waiver to prescribe buprenorphine in an office-based setting.

  • The ASAM Review Course in Addiction Medicine 2018 (20.5 CME)

    Contains 24 Product(s)

    Earn up to 20.5 CME while preparing for the ABPM Addiction Medicine Exam using this on-demand package of courses, containing the conference recordings, resources, practice questions, and slides from The ASAM Review Course in Addiction Medicine, 2018. The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

  • Talking to Patients About Health Risk Behaviors

    Contains 3 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1™ credits while learning about motivational interviewing. This highly interactive course takes a case based approach to helping you learn about motivational interviewing. You will start by learning about the major elements of motivational interviewing. You will then be guided through a case to help you identify opportunities to use principles of motivational interviewing in patient encounters. You will begin to plan appropriate responses based on patients’ descriptions of challenges and opportunities for change.

  • ASAM 49th Annual Conference - Innovations in Addiction Medicine and Science - 2018 (64.5 CME)

    Contains 49 Product(s)

    Earn a maximum of 64.5 AMA PRA Category 1™ credits while learning about the latest innovations in Addiction Medicine and Science from these on-demand conference recordings from the nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine.

  • Treating Youth with Opioid Addiction: Cases and Controversies (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to treat youth with opioid addiction while employing developmentally specific approaches, using relapse prevention medication (MAT), from this conference recording from The ASAM 49th Annual Conference (2018). The session also includes when and how to involve families, as well as a discussion on issues in confidentiality and the use of various levels of care.

  • Integrating Addiction Treatment into General Medical Health Systems (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to integrate addiction treatment into general medical health systems, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Peering Through the Smoke: Update on Adolescent and Young Adult Tobacco Use (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning how to recognize trends in adolescent tobacco use from this conference recording from The ASAM 49th Annual Conference (2018).

  • Bridging Gaps: Developing Immediate Access SUD Care in the Face of Crisis (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning learn what an immediate access, low threshold, transitional drop-in clinic looks like, treating close to 500 patients with Substance Use Disorder since 2016, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Fentanyl and Analogs, Oh My: Their Impact on Patients and Public Health (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the myths and facts of fentanyl and analogs from this conference recording from The ASAM 49th Annual Conference (2018).

  • New Approaches Using Contingency Management to Reduce Substance Use in the CJS (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about innovative ideas for reducing the substance use of individuals who are under criminal justice supervision and review evidence on program effectiveness, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Navigating the Minefield of Substance Use Testing: Understanding Your Patient's Report (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the common pitfalls to urine and oral fluid drug testing from this conference recording from The ASAM 49th Annual Conference (2018).

  • Reducing Alcohol-Related Emergency Visits: An Innovative Model of Care to Improve Outcomes (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about an innovative rapid access medical withdrawal management service from this conference recording from The ASAM 49th Annual Conference (2018).

  • Medications for Opioid Use Disorder: A Toolkit for Improving Practice (TIP) (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about SAMHSA's Toolkit for Improving Practice, or TIP, in response to the opioid crisis under the Comprehensive Addiction and Recovery Act of 2016, which outlines up-to-date information about using medications to treat OUD in order to expand the use of effective treatments, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Psychiatry for Non-Psychiatrists: The DSM-5 Express (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about psychiatric and medical co-morbidities from a psychiatrist perspective. This conference recording from The ASAM 49th Annual Conference (2018), serves as a fundamentals of psychiatry and is designed strictly for non-psychiatrist addiction medicine professionals.

  • Hepatitis C Prevention, Management and Treatment for Addiction Medicine Practitioners (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ , while learning how to summarize and describe CDCs Hepatitis C testing and treatment guidelines, and describe successful models of programs in opioid substitution treatment programs and addiction treatment centers, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Implementing MAT into Federally Qualified Health Centers: Challenges and Solutions (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about different models of office-based opioid treatment, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Improving Treatment for Opioid Use Disorders: A System-Wide Approach (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to to improve clinical outcomes within treatment systems in which patients with addiction involving opioids receive care, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Motivational Interviewing: Brushing up on the Basics (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how Motivational Interviewing (or MI), has been transformational in medical care since it's release in 2013, from this conference recording from The ASAM 49th Annual Conference (2018).

  • SUD Patients and Pain: The Multi-Faceted and Ever Changing Clinical Challenges (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the frequently encountered issues, as well as the substantial evolution in the management of older challenges, as well as the emergence of new issues in the interface between pain and addiction, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Annual Review of Addiction Medicine Highest Impact Publications (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about Addiction Medicine's highest impact, peer-reviewed journal articles across the field of Addiction Medicine from 2017-2018, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Leveraging Technologies and EHR in SUD Treatment: NIDA CTN Research Initiatives (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to implement evidence-based practices in the management of substance use disorders, especially opioid use disorders, from this conference recording from The ASAM 49th Annual Conference (2018).

  • Forgiveness and Addiction: Addressing Resentment, Guilt, and Shame in Recovery (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning the skills that can facilitate the implementation of forgiveness in clinical practice, from this conference recording from The ASAM 49th Annual Conference (2018).

  • ASAM Fundamentals of Addiction Medicine Online Workshop (8 CME)

    Contains 14 Component(s), Includes Credits

    This online workshop is an innovative, case-based 8-hour online course designed for providers who are relatively new to the field of addiction medicine, such as primary care physicians, clinicians, and behavioral health specialists, who see patients at risk for or with addiction. (Activity 1 of 5 for the ASAM Fundamentals of Addiction Medicine 40-Hour Program)

  • ASAM 48th Annual Conference - Innovations in Addiction Medicine and Science - 2017 (71 CME)

    Contains 56 Product(s)

    The nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine.

  • Evaluating Drug Dependence: Regulatory, Methodological and Clinical Challenges (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Evaluating drug withdrawal effects is an integral component of dependence potential, which informs the overall safety, appropriate dosing, and scheduling of a drug. Understanding withdrawal phenomenon is critical in the care and management of patients who are physically dependent on medication or drugs of abuse. This workshop will address the regulatory and methodological considerations that are rapidly evolving in this active area of research and will cover case examples of studies examining drug withdrawal and dependence. In addition, the clinical relevance of dependency and mitigation of symptoms in the clinical setting will be discussed.

  • New Frontiers in the Treatment of Co-Occurring Alcohol Use Disorder and Anxiety (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    In this presentation, I will provide a critical review of two key assumptions that have driven much of the comorbidity research over the past 35 years (since the introduction of DSM III): that the various subtypes of anxiety disorder like social phobia each have a distinct relationship to alcohol use disorder and that alleviating a co-occurring anxiety disorder through conventional psychiatric treatments, either alone or in conjunction with AUD treatment, is the most effective clinical response to comorbidity.

  • Clinical Case Presentations and Interactive Discussion (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Clinical cases involving alcohol use disorder, methadone induced QTc prolongation, traumatic brain injury (TBI), and pain and addiction, will be presented and discussed. This session is meant to be interactive, with participants discussing how they would manage the clinical dilemmas.

  • Integrating Recovery Coaches into General Medical Settings (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    “Recovery coaches” (RCs), peers sharing the lived experience of addiction and recovery, are increasingly being integrated into general medicine. RCs can help fill the large substance use disorder treatment gap and partner with vulnerable patients to help them connect with and navigate healthcare and other services. Building off of a hospital system-wide RC program and qualitative study on the RC role, this workshop will introduce participants RCs and use a step-by-step, interactive case study to walk participants through designing a recovery coach program for their practice.

  • Culture Shifting: Integrated Treatment of Opioid Use Disorder in Hospital Systems (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Medication treatments for opioid addiction have been validated in primary care and hospital based settings. Despite the clinical potential associated with medications for addiction treatment, there has been limited adoption of pharmacotherapies in the treatment of opioid use disorder in these settings. This focus session will review strategies to integrate the delivery of pharmacotherapies in the treatment of opioid use disorder in primary care and hospital settings.

  • Combatting the Opioid Epidemic by Expanding Medication Assisted Treatments (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The United States is in the midst of an unprecedented opioid epidemic resulting in serious morbidity and mortality. More people died from drug over dose in 2014 than in any year on record and more than 60% involved an opioid. The Department of Health and Human Services announced an initiative to reduce prescription opioid overdose by expanding the use of Medications Assisted Treatment (MAT) that combines the use of medication with counseling to treat Substance Use Disorders (SUDs).

  • Addiction Medicine Can Save Lives and Treat Addiction During and After Incarceration (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Incarcerated populations have high rates of substance use disorders (SUDs), yet treatment of these disorders is rare in US jails and prisons. This workshop will explore some of these models and the changing landscape of options for improving the health of incarcerated persons who have OUD and other SUDs. We will describe innovative models from 2 states, and will offer small group discussion about how to expand treatment in your own community.

  • Addiction Medicine 2.0- Practicing on the Cloud (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This session will explore the emerging role of telemedicine in the provision of addiction medicine care, particularly in small and/or remote communities.

  • Contingency Management in General Treatment Populations and Special Groups (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Contingency management (CM) is a powerful treatment approach with strong empirical support and large effects, but which is underutilized in community treatment. This workshop will provide information and interactive experience to explore the barriers to CM use and encourage implementation of practical, cost-effective techniques.

  • Methadone & Long QTc: Clinical Prediction, 5-Year Prevalence, and Causes-Interventions (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The goal of the session is the prevention and early intervention of long QTc in patients receiving methadone maintenance treatment (MTT). The presentations are based on observations made over a five-year period in a MMT program. These observations range across a novel clinical biomarker, epidemiological observations made over 300 patient-years, along with clinical diagnosis, intervention, and outcome. We will engage our participants such that they can apply our findings to their clinical populations receiving MMT.

  • Vermont Hub and Spoke Model of Care for Opioid Use Disorders (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Vermont established a Chronic Care Initiative that made opioid use disorder part of the Blueprint for Health and designated funding for an integrated model of care linking medical providers with regional Opioid Treatment programs (designated as hubs) and provided Community Health teams to assist buprenorphine prescribers (designated as spokes) in their practices. We describe this model and successes showing total increase in treatment enrollees, increase in number of physicians waived to prescribe buprenorphine and numbers of patients per provider, provision of a triage tool to determine hub or spoke placement and use of a learning collaborative to increase overall knowledge base statewide for opioid use disorder treatment.

  • Ethical Issues in Addiction Medicine- Case Based Dilemmas (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Ethical issues abound in caring for patients with addiction, with clinical dilemmas related to difficult patients, manipulative behavior, refusal of care and legal issues. The workshop will briefly review the ethical principles of Autonomy, Beneficence, Non-maleficence, Justice, Fidelity and Futility. The understanding of these terms will serve as the basis of case based discussions.

  • Hepatitis C Screening, Education, and Treatment Program for People Who Use Drugs (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This workshop will examine unique models of interdisciplinary HCV care delivery tailored to different clinical settings where persons who use drugs may present including: primary care, opioid treatment programs, syringe exchanges, and safety net programs for the homeless. We will review basics of treatment models after which we will hold an interactive session where small groups will review pertinent cases.

  • Integrative Health and Addiction Medicine: Treating the Whole Person (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    An interactive workshop that will introduce Integrative Addiction Medicine by giving a context for this whole person treatment approach, and providing a 'sampler' of clinical approaches that will include: nutrition, mindfulness, supplements, sleep and CAM case examples. Some of the evidence-base will be presented. This workshop will include interactive tools that will be practiced within the workshop, time for discussion, and will end with participants creating their own practice-change action plan.

  • A Low Threshold Clinic for Medically Complex Patients with Substance Use Disorder (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The Mass General Bridge Clinic is an immediate access clinic which provides low threshold transitional support and treatment to patients following hospitalization or directly from the emergency department (ED) and other outpatient clinics. The clinic predominantly serves individuals who would otherwise be unable to access care. The goal of the clinic is first and foremost engagement, followed by rapid treatment initiation, stabilization, and linkage to community-based treatment. This focus session will describe the nuts and bolts of starting and running this type of a clinic model, review lessons learned, and discuss early outcomes.

  • Thriving Under Value-Based Reimbursement with Behavioral Screening and Intervention (BSI) (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    As value-based reimbursement continues to expand, healthcare organization leaders increasingly appreciate the importance of behavioral health but aren’t sure what to do about it. Simply hoping that providers will recognize and treat or refer patients for behavioral health issues will no longer “cut it.” In this session, attendees will learn how to advise healthcare leaders on Behavioral Screening and Intervention, an evidence-based, cost-saving, proactive approach to identifying and addressing behavioral risks and disorders.

  • Using Project ECHO to Spread Office-Based MAT: Life-Saving System Transformation (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    In this presentation, we will review a brief history of the separation of addiction treatment from the medical establishment. We will introduce the Harm Reduction model, and compare how that model fits with traditional treatment models as opposed to with Medication-Assisted Treatment (MAT). We will share our process of building a MAT program in a rural primary care network, including our use of the Extension of Community Healthcare Outcomes (ECHO) model to build competency in including MAT as part of comprehensive primary care.

  • Teamwork Training to Enhance Effectiveness and Patient Safety in Addiction Medicine (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The presenters will provide an introduction to the concepts of teamwork enhancement as it may apply to care providers within the field of addiction care. Attendees may identify areas in which opportunities for improvement exist in their current or past working environment.

  • Using PMP's and SBIRT to Address Physician Controlled Drug Prescribing (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The prudent prescribing of controlled drugs has been a challenge for decades. Balancing prescribing for legitimate medical purpose while avoiding prescribing in high risk situations has been one of the most difficult aspects to address. This is partly due to suboptimal screening for high risk patients by prescribers prior to and during chronic controlled drug prescribing. The development of US Prescription Monitoring Programs has brought about the clinical expectation that Substance Abuse Treatment Programs (SATPs) will perform a PMP web-site search on all patients evaluated for problematic substance use.

  • Substance Withdrawal in Pregnancy: From Research to Practice to Public Health (2 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Jim Walsh and Vania Rudolf will address challenges and practical considerations for OAT and summarize its benefits for maternal and neonatal outcomes when compared to medication assisted withdrawal management.

  • Marijuana: From Bench to Policy (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    There are controversies regarding marijuana in the development of current public policy in the United States through legalization and/or decriminalization of medical marijuana and recreational marijuana throughout the nation, and worldwide as well. Informed addiction physicians are best qualified to opine, advise and advocate for improved public policy regarding marijuana use, access and promotion. This symposium will provide opinion survey data of ASAM and ISAM physicians. Overall perspectives from highly qualified scientists and professionals related to the impact of marijuana policies on individuals, families and communities in diverse cultural settings will be presented.

  • Engaging Healthcare Practitioners to Address the Opioid Crisis (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This session will review: Survey data of NPs interest in treating OUD and obtaining a waiver to prescribe MATs; Potential barriers for NPs related to prescribing MATs and Current status of number of NPs that have registered for the required 24 hours of education for waiver application.

  • Interventional Pain Management: A Pain Control Strategy for the Patient in Treatment (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The presentation will include vignettes of treatment options for problems that are commonly seen in both the pain management office, and the addiction treatment setting. A brief overview of the type of available procedures, and their risks and options will be discussed. We will then allow time for questions. Drs. Hansen and Silverman are both active and Board members of the American Society of Interventional Pain Physicians, which is a group of physicians and extended care providers that train and provide resources to treat our patients in pain. Their experience in pain medicine and addiction medicine allow them to present a perspective that is unique to the complex patient in treatment and pain.

  • Role of Pediatricians in the Prevention, Assessment &Treatment of Substance Use Disorders (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    Nearly all substance use disorders (SUDs) can be traced to adolescence, when the vulnerable adolescent brain is first exposed to psychoactive substances. With a backdrop in brain biology, this presentation will present the clinical and policy implications for managing the highly prevalent chronic and serious problem of SUDs in this high-risk population. We will review the AAP guidance for pediatricians and discuss strategies for providing SBIRT (Screening, Brief Intervention and Referral to Treatment) in primary care clinical settings.

  • Implementing Tobacco-Free Policies in Residential Addiction Treatment Settings (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This workshop shares the experiences of three residential addiction treatment center implementing tobacco-free policies. We will review the epidemiology of tobacco use disorders with respect to patients with other substance use disorders. We will have small group discussion to facilitate how each workshop participant could implement tobacco-free policies at their respective programs.

  • Addressing Adolescent Substance Use: How to Recognize, Screen, and Communicate (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This session will feature a curriculum on addressing adolescent substance use and disorders in general medical practice, developed by a broad coalition of stakeholders with funding from the Hilton Foundation, featuring a substantial contribution by ASAM.

  • Developing Effective Teams for Patient-Centered Care (1 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    In today’s healthcare environment, data continues to support an integrated, team approach to obtaining the best patient outcomes. This session will look at how to identify community resources as well as best practices in integration and team care.

  • Opening Scientific Plenary & Distinguished Scientist Lecture (2 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    The opening session will focus on the dawn of a new day in addiction medicine with an exciting lineup of ASAM award winners and luminaries in the field.

  • Addiction 60/60: All of Addiction Medicine in 60 Slides and 60 Minutes (1.5 CME)

    Contains 3 Component(s), Includes Credits

    This session offers an ultra-fast-paced, “state-of-the-art” review of 2017 Addiction Medicine in the context of our current understanding of the addictive process. We will review how current neurobiology approaches craving and control, and how these novel concepts inform our treatment options, both pharmacological and psychosocial.

  • Fetal Alcohol Spectrum Disorders: Prevention, Diagnosis and Management in Primary Care (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This interactive, multimedia focus session will provide the primary care clinician a primer on addressing unhealthy alcohol exposure across the lifespan with a focus on FASDs diagnosis, management and prevention. We will discuss how to screen for, diagnosis, manage and refer patients with FASDs in the primary care setting. We will also review two evidence-based approaches to alcohol exposed pregnancy prevention in primary and integrated care systems, alcohol Screening and Brief Intervention (aSBI) and the CHOICES interventions. Lastly we will share strategies to promote a safe and supportive, stigma-free practice environment for patients with FASDs and their families.

  • Opioid Overdose and Substance Use Disorder Treatment: Prevention and Response Strategies (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This workshop session will provide an opportunity for attendees to learn about SAMHSA’s detailed overdose prevention and response curriculum including its purpose, content, and how to use and adapt it. Presenters will discuss strategies for overdose prevention and SAMHSA’s priorities and prevention efforts for addressing the nation’s heroin/opioid overdose epidemic. The discussion will include details of increasing naloxone access such as considerations related to naloxone product(s), liability discussions for organizations and individuals, and adapted agency protocols. Presenters will also share lessons learned about working with community stakeholders and developing collaborative interagency relationships to address opioid overdose prevention using naloxone.

  • The Nuts and Bolts of the Inpatient Substance Use Disorders Consultation (1.5 CME)

    Contains 3 Component(s), Includes Credits

    ​Substance use disorders are common, with a 12-month prevalence in the general population of 14% for alcohol and 4% for drug use disorders, respectively. Rates among hospitalized patients are notably higher with estimates of current substance use disorders among inpatients of up to 30%. Prior studies have suggested that hospitalization may be a "reachable moment" and is an ideal time to intervene with patients who have substance use disorders. This presentation will describe the procedures of an inpatient addiction consultation service.

  • Improving Physician Assessment and Treatment Outcomes: When a Physician is the Patient (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This workshop will help physicians and other healthcare providers to better understand their profession’s unique risk factors for adverse outcomes such as substance abuse, suicide and burnout. Additionally, it will help providers who are in the position of evaluating and/or treating a colleague or fellow healthcare provider to obtain better outcomes and to provide optimal diagnostics and treatment.

  • The Rational Understanding and Use of Urine Drug Testing in Addiction Medicine (1.5 CME)

    Product not yet rated Contains 3 Component(s), Includes Credits

    This workshop presentation will tackle the controversies related to urine drug testing and explore possibilities for best practices in various practice settings. Laboratory and testing technologies will be described with a look at the sensitivity and specificity of the testing type as well as considerations of cost to the patient and cost (staff time, supplies) to the provider in these various settings.

  • The ASAM Pain & Addiction: Common Threads Course XVIII 2017 (7.5 CME)

    Product not yet rated Contains 5 Product(s)

    Participants will have the opportunity to learn about the new research and clinical guidelines on treating patients with pain and addiction and how to apply these to improve patient outcomes.